COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
Cosmic Ray MuographyAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact William Fawcett. Muons are fundamental, charged particles that form part of our naturally-occurring background radiation. They are produced in particle showers in the upper atmosphere from the impact of cosmic rays. These muons are incident at sea-level at a rate of about one per square centimetre per minute and with average energies of about 3 GeV—approximately four orders of magnitude more than typical X-rays. Muons are highly penetrating and can traverse hundreds of metres of rock, which has opened up the possibility to use them for challenging imaging applications. Muography is an established technique in volcanology, it has been used to find a cavity in the pyramid of Khufu in Egypt and over the last years a wide variety of applications have been explored—ranging from cargo screening to nuclear waste characterisation and carbon storage monitoring. Lynkeos Technology is a spin-out company from the University of Glasgow, founded in 2016 following a 7-year, £4.8M research programme funded by the NDA . The Lynkeos Muon Imaging System is the worldwide first, CE-marked muon imaging system for the characterization of nuclear waste containers. It has been successfully deployed on the Sellafield site in October 2018. This talk will give an overview of muography applications worldwide and present the activities of Lynkeos Technology in detail, with a focus on the characterization of nuclear waste containers. This talk is part of the Cavendish HEP Seminars series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsReplication, Recombination, Repair: 3R's Seminar Series TEDxOxbridge BN SeminarsOther talksScience & Engineering Treatment of kidney cancer Designer tissues: synthetic, living and hybrid materials Cancer metabolism, a hallmark of cancer Lung Cancer: Part 1. Patient pathway and intervention. Part 2. Lung Cancer: Futurescape Projects and Medical Devices within the NHS |